,49 On the other hand, personalised dosimetry such as partition model relies on differential tumour-to-non-tumour perfusion evaluated on pre-treatment Technetium-99m-macroaggregated albumin single-photon emission computer tomography combined with computer tomography to predict dose distributions between the “partitions” tumoural liver, non-tumoural liver, and lung. Here, ALB is linked to neoplasm.